Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens may help treat conditions like excessive hair growth, prostate tumors, male baldness, and acne by blocking male hormone effects.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

There might be a link between male pattern baldness and a higher risk of prostate cancer and testicular cancer.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

A new compound was made that might help treat diseases related to male hormones.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

ERG increases SOX9, promoting prostate cancer growth and invasion.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Alopecia should be treated as a medical condition because it may increase the risk of serious diseases and psychological issues.

The compound was successfully made and shows potential for treating prostate cancer.

Gene variation affects prostate issues and hair loss.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Testosterone may influence COVID-19 severity and outcomes.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.